Burzynski: Egypt antineoplaston publications

7/3/2000 – (A10) – Potential utility of antineoplaston A-10 levels in breast cancer
http://www.ncbi.nlm.nih.gov/pubmed/10814881
Cancer Lett 155:67-70, 2000
http://www.ncbi.nlm.nih.gov/m/pubmed/10814881
Cancer Lett 155(1):67-70 (2000)
http://www.cancerletters.info/article/S0304-3835(00)00408-0/abstract
Cancer Lett. 2000 Jul.3;155(1):67-70
http://www.sciencedirect.com/science/article/pii/S0304383500004080
DOI: 10.1016/S0304-3835(00)00408-0
Cancer Letters, Elsevier Science
http://www.sciencedirect.com/science/article/pii/S0304383500004080
Department of Pharmacognosy, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt
======================================
8/31/2000 – Immune modulatory potentials of antineoplaston A-10 in breast cancer patients
http://www.ncbi.nlm.nih.gov/pubmed/10893443
Cancer Lett 157: 2000
http://www.ncbi.nlm.nih.gov/m/pubmed/10893443
Cancer Lett 157 (1):57-63 (2000)
http://www.cancerletters.info/article/S0304-3835(00)00472-9/abstract
Cancer Lett. 2000 Aug.31;157(1):57-63
http://www.sciencedirect.com/science/article/pii/S0304383500004729
(Cancer Lett., 2000, 157, 57)

Click to access A10-Cancer%20Letters%20157.pdf

Cancer Lett 157: 57-63, 2000
Cancer Letters – Elsevier
Cancer Letters, Elsevier Science
DOI: 10.1016/S0304-3835(00)00472-9
Department of Pharmacognosy, Faculty of Pharmacy, Mansoura University, Egypt
======================================
12/2000 – (antineoplaston A10) – Novel piperidinedione analogs as inhibitors of breast cancer cell growth
http://www.ncbi.nlm.nih.gov/pubmed/11199474
333 (12):431-4 (2000)
http://www.ncbi.nlm.nih.gov/m/pubmed/11199474
DOI: 10.1002/1521-4184(200012)333:123.0.CO;2-M
http://onlinelibrary.wiley.com/doi/10.1002/1521-4184(200012)333:12%3C431::AID-ARDP431%3E3.0.CO;2-M/abstract
Arch Pharm (Weinheim), John Wiley & Sons, Inc.
Department of Medicinal Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt
======================================
10/1/2001 – Synthesis, spectroscopic characterization, stability assessment and DNA-binding of new 2,6-piperidinedione derivatives
superior affinity to the DNA than the prototype ANP-A10
http://www.ncbi.nlm.nih.gov/pubmed/11718269
Farmaco. 2001 Oct; 56 (10): 763-70
http://www.ncbi.nlm.nih.gov/m/pubmed/11718269
Farmaco Prat 56 (10):763-70 (2001)
http://www.sciencedirect.com/science/article/pii/S0014827X01011314
Il Farmaco, Elsevier
Il Farmaco, Volume 56, Issue 10, Pages 763–770
Elsevier Science
Department of Medicinal Chemistry, Faculty of Pharmacy, Mansoura University, Egypt

Advertisement